UCB To Acquire Candid Therapeutics For Up To $2.2 Bln To Boost Immunology Pipeline
4/5 07:25
(RTTNews) - United Community Banks, Inc. (UCB),on Sunday agreed to buy Candel Therapeutics, Inc. (CADL) for up to $2.2 billion, aiming to strengthen its pipeline of treatments for immune-related diseases....